Investing.com -- MongoDB (NASDAQ:MDB), once a high-flying software darling, is facing calls from investors for a shake-up, as shares remain down more than 50% from their 52-week high and full-year guidance reveals a sharp deceleration in growth. With pressure building, investors are increasingly hoping that a large activist investor will step in to force operational changes and potentially push the company to explore a sale of the business. The database platform provider reported solid fiscal Q4 results, beating earnings and revenue expectations with EPS of $1.28 versus consensus estimates of $0.66 and revenue of $548.4 million against $520.5 million expected. However, the market’s focus quickly shifted to FY 2026 guidance, which disappointed on both the top and bottom line. Revenue is projected at $2.24 billion to $2.28 billion, below the $2.32 billion analysts had forecast, while full-year EPS is expected to come in between $2.44 and $2.62, well under the $3.39 consensus estimate. The stock reaction has been stark. Despite MongoDB’s long record of innovation and substantial revenue growth since its 2017 IPO, the market is now digesting the reality that the company is transitioning from a high-growth narrative to a more mature, slower-growth business model. And with that transition, investors say, should come a reassessment of cost structure and strategy. One area of particular focus is MongoDB’s operating expenses, which remain steep relative to its current cash flow profile. The company spent nearly $600 million on research and development in fiscal 2025, roughly four times the $150 million it generated in operating cash flow. General and administrative costs totaled an additional $220 million. Investors see an opportunity for significant margin improvement through more aggressive cost controls. Randian Capital, an investor who has followed MongoDB since its early days as a public company, pointed to this misalignment between growth and expense as a key issue, in exclusive comments made to Investing.com. “MDB is spending almost $600mm per year on R&D, relative to a company that generated $150mm in cash from operations in 2025,” Randian wrote. The firm believes “the time is right for MDB to cut costs meaningfully across R&D and the $220mm in annual G&A costs.” Beyond cost discipline, investors, such as Randian, believe MongoDB should consider strategic alternatives, including a possible sale. With a growing list of slowing software businesses becoming acquisition targets, some argue that MongoDB’s product and market position make it highly attractive to both strategic buyers and private equity. Large tech players such as Amazon (NASDAQ:AMZN), Oracle (NYSE:ORCL), IBM (NYSE:IBM), and SAP have been floated as potential suitors, and an LBO has also been seen as a viable option. Story Continues “MongoDB should explore a sale process,” Randian added, noting that “MDB presents a rare case of a business that has a large cost cut opportunity and clear visibility of many years of growth ahead.” While MongoDB’s leadership under CEO Dev Ittycheria has garnered praise for guiding the company from a niche open-source project to a widely adopted enterprise platform, the business has entered a more mature phase. FY 2026 marks what may be the first year of consistent low double-digit revenue growth after years of 30%-plus expansion. For some investors, that inflection point makes the case for external involvement to reassess capital allocation and long-term positioning. A properly executed turnaround, paired with a potential monetization event, could help rebuild investor confidence, many argue. MongoDB’s highly differentiated technology, particularly its appeal to developers working on flexible, scalable applications, remains valuable in a software market looking for durable platforms. For now, no activist investor has taken a public stake, but the conditions —profitability potential, underperformance, and strategic interest —are increasingly aligned. With renewed scrutiny on costs and a growing call to evaluate all options, the company may soon be forced to respond to the pressures building from its investor base. Related articles Investors eye activist intervention as MongoDB struggles with growth and valuation Airbus tops Q1 expectations as production set to ramp up Pichai pushes back on antitrust remedies, hints at Apple Gemini talks View Comments
Investors eye activist intervention as MongoDB struggles with growth and valuation
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...